Compare drug alternatives
Emgality® Alternatives
Emgality®(galcanezumab) | Vyepti®(eptinezumab) |
---|---|
Prescription Only | Prescription Only |
Dosage & Administration | |
Administration | |
Subcutaneous. Learn more. | Intravenous infusion (must be diluted). Learn more. |
Dosing | |
Migraine: 240 mg loading dose (120 mg x 2) followed by 120 mg monthly. . Learn more. | 100 mg every 3 months or 300 mg (for some patients). Learn more. |
Latin Shorthand | |
240 mg LD (120 mg x 2) then 120 mg/mo.. Learn more. | 100 mg q3mo. Learn more. |
Adverse Reactions | |
The most common adverse reactions (incidence ≥2% and at least 2% greater than placebo) in EMGALITY clinical studies were injection site reactions. . Learn more. | The most common adverse reactions (≥2% and 2% or
greater than placebo) were nasopharyngitis and
hypersensitivity.. Learn more. |
Financial Assistance | |
Out-Of-Pocket Costs With Copay Card | |
$0. Learn more. | $0. Learn more. |
Annual Cap | |
$4900. Learn more. | $200 per infusion for administration costs. Learn more. |
Assistance Expiration | |
12 months. Learn more. | Calendar year. Learn more. |
Generics | |
No lower-cost generic available | No lower-cost generic available |
Popular Alternatives
- Emgality® vs Ubrelvy®
- Emgality® vs Qulipta®
- Emgality® vs Ajovy®
- Emgality® vs Aimovig®
- Emgality® vs Nurtec ODT®